Seer Total Assets 2021-2021 | SEER

Seer total assets from 2021 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Seer Annual Total Assets
(Millions of US $)
2020 $0
Seer Quarterly Total Assets
(Millions of US $)
2021-09-30 $0
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.963B $0.001B
Seer Inc. is a life sciences company. It engages in developing Proteograph(TM), which is an integrated solution consisting of consumables, automation instrumentation and proprietary software. Seer Inc. is based in REDWOOD CITY, Calif.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $141.036B 8.91
Bio-Rad Laboratories (BIO.B) United States $17.472B 35.46
QIAGEN (QGEN) Netherlands $11.101B 18.80
Biohaven Pharmaceutical Holding (BHVN) United States $7.210B 0.00
Emergent Biosolutions (EBS) United States $2.527B 9.09
Arcus Biosciences (RCUS) United States $2.184B 0.00
Myovant Sciences (MYOV) United Kingdom $1.260B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.080B 0.00
Zymeworks (ZYME) Canada $0.522B 0.00
SQZ Biotechnologies (SQZ) United States $0.201B 0.00
Ambrx Biopharma (AMAM) United States $0.191B 0.00
Enzo Biochem (ENZ) United States $0.154B 19.81